Author

P. Bost

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. Posseme· 2 shared D. Duffy· 2 shared V. Bondet· 2 shared A. Llibre· 1 shared B. Charbit· 1 shared B. Schwikowski· 1 shared C. Mauri· 1 shared D. Hunt· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Posseme

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential levels of IFNα subtypes in autoimmunity and viral infection

V. Bondet, M. P. Rodero, C. Posseme, P. Bost, J. Decalf, L. Haljasmagi, N. Bekaddour, G. Rice, V. Upasani, J.-P. Herbeuval, J. A. Reynolds, T. A. Briggs, I. N. Bruce, C. Mauri, D. Isenberg, , D. Duffy

The paper develops an ultrasensitive ELISA for IFN2 and applies it to study IFN subtype responses in viral infection and autoimmunity, revealing distinct protein ratios and potential auto-antibody effects.

bioRxiv · Mar 4, 2021 · PreprintImmunology

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

A. Llibre, N. Smith, V. Rouilly, M. Musvosvi, E. Nemes, C. Posseme, S. Mabwe, B. Charbit, S. Kimbung Mbandi, E. Filander, H. Africa, V. Saint-Andre, V. Bondet, P. Bost, H. Mulenga, , D. Duffy

The paper examines how tuberculosis alters immune-metabolic pathways, leading to changes in IL-1 responses in TB patients compared to latent infection and post-treatment.

bioRxiv · Dec 17, 2020Immunology